ÃØÃÜÑо¿Ëù

Internal Server Error
Unlock full details of this profile with our freeÌýLiteÌý±è±ô²¹²Ô!
Signup and get free access

soonicorn
Last updated:

Lygos - About the company

Lygos is a series B company based in Emeryville (United States), founded in 2010. It operates as a Manufacturer of green acids from microbes. Lygos has raised $51.8M in funding from investors like IA Ventures, and First Round Capital. The company has 2305 active competitors, including 600 funded and 394 that have exited. Its top competitors include companies like Amyris, Avidity Biosciences and Arbor Biotechnologies.

Company Details

Manufacturer of green acids from microbes. It employs synthetic biology techniques to generate microbial catalysts to convert agricultural feedstocks into fine and commodity chemicals. Its high throughput screening and strain construction facilitate the optimization of pathways to convert the renewable feedstock to high-value chemicals. Its product portfolio includes malonic, lactic, isobutyric, aspartic, glyceric, and glycolic acids.
Website
Social
Key Metrics
Founded Year
2010
Location
Emeryville, United States
Stage
Series B
Total Funding
in 23 rounds
Latest Funding Round
Investors
Ranked
Employee Count
as on Dec 31, 2023
Similar Companies

Legal entities associated with Lygos

Lygos is associated with 1 legal entity given below:
Legal Entity Name
Date of incorporation
Revenue
Net Profit
Employee Count
-
223
462
Get your free copy of Lygos's company profile

Lygos's funding and investors

Lygos has raised a total funding of $51.8M over 23 rounds. Its first funding round was on 2011. Its latest funding round was a Series B round on Feb 09, 2021 for an undisclosed amount. 2 investors participated in its latest round, which includes First Round Capital, , Brainchild and Catapult.

Lygos has 21 institutional investors including IA Ventures, and First Round Capital.

Here is the list of recent funding rounds of Lygos:
Date of funding
Funding Amount
Round Name
Post money valuation
Revenue multiple
Investors
Feb 09, 2021
Undisclosed
Series B
1817001
5885948
Jul 03, 2019
$2M
Grant (prize money)
5770731
5508131
Apr 16, 2019
$10.9M
Series B
7003555
1629803
-
lockAccess funding benchmarks and valuations. Sign up today!

Lygos's founders and board of directors

Lygos's employee count trend

Lygos has 63 employees as of Dec 23. The total employee count is 57.5% more than what it was in Dec 22. Here is Lygos's employee count trend over the years:
Employee count trend for Lygos
lockUncover Lygos's growth story! Sign up today!

Lygos's Competitors and alternates

Top competitors of Lygos include Amyris, Avidity Biosciences and Arbor Biotechnologies. Here is the list of Top 10 competitors of Lygos, ranked by ÃØÃÜÑо¿Ëù score :
Overall Rank
Company Details
Short Description
Total Funding
Investors
ÃØÃÜÑо¿Ëù Score
1st
Logo for Amyris
Amyris
2003, Emeryville (United States), Public
Developer of renewable products for industrial solutions
$487M
Hercules Capital, TPGÌý&²¹³¾±è;Ìý
79/100
2nd
Logo for Avidity Biosciences
Avidity Biosciences
2012, San Diego (United States), Public
Develops antibody-siRNA complexes to treat cancer
$143M
TPG, Perceptive AdvisorsÌý&²¹³¾±è;Ìý
74/100
3rd
Logo for Arbor Biotechnologies
Arbor Biotechnologies
2016, Cambridge (United States), Series C
Provider of genomic technologies and drug discovery platform
$304M
73/100
4th
Logo for Univercells
Univercells
2013, Charleroi (Belgium), Series D
Provider of biomanufacturing technology services for biopharma sector
$151M
KKR, In-Q-TelÌý&²¹³¾±è;Ìý
71/100
5th
Logo for Sutro Biopharma
Sutro Biopharma
2003, San Francisco (United States), Public
Developer of antibody-based therapeutics for cancer therapy
$175M
73/100
6th
Logo for Evonik
Evonik
2007, Essen (Germany), Public
Manufacturer of speciality chemicals
-
KKR, CVCÌý&²¹³¾±è;Ìý
70/100
7th
Logo for Vividion Therapeutics
Vividion Therapeutics
2016, Oceanside (United States), Acquired
Developing novel drugs based on a proteome-wide ligand and target discovery platform
$271M
70/100
8th
Logo for Relay Therapeutics
Relay Therapeutics
2016, Cambridge (United States), Public
Developer of drug discovery platform and study protein motion
$520M
Foresite Capital, Perceptive AdvisorsÌý&²¹³¾±è;Ìý
70/100
9th
Logo for Straumann Group
Straumann Group
1954, Basel (Switzerland), Public
A portfolio of dental products
-
69/100
10th
Logo for Korro Bio
Korro Bio
2018, Cambridge (United States), Public
Provider of RNA-editing technologies for precision medicine
$4M
69/100
25th
Logo for Lygos
2010, Emeryville (United States), Series B
Manufacturer of green acids from microbes
$51.8M
First Round Capital, Ìý&²¹³¾±è;Ìý
61/100
lockGet insights and benchmarks for competitors of 2M+ companies! Sign up today!
Looking for more details on Lygos's competitors? Click to see the top ones

Lygos's Investments and acquisitions

Lygos has made no investments or acquisitions yet.

Reports related to Lygos

Here is the latest report on Lygos's sector:
View

News related to Lygos

Media has covered Lygos for a total of 3 events in the last 1 year, 2 of them have been about company updates and 1 about partnerships.
•
Business Wire•Sep 10, 2024•Lygos, CJ CheilJedang BIO
•
Business Wire•May 14, 2024•Lygos
•
Business Wire•Apr 23, 2024•Lygos
•
Business Wire•Oct 24, 2023•Lygos
•
Business Wire•Oct 16, 2023•Lygos, CJ
•
Business Wire•Sep 05, 2023•Lygos
•
Business Wire•Jul 11, 2023•Lygos
•
Seeking Alpha•Nov 11, 2022•Ginkgo Management Consulting, Lygos, Ginkgo Bioworks
•
Business Wire•Oct 11, 2022•Lygos
•
GlobeNewswire•Oct 01, 2022•Flexible Solutions, Lygos
lockGet curated news about company updates, funding rounds, M&A deals and others. Sign up today!

Frequently asked questions about Lygos

When was Lygos founded?
Lygos was founded in 2010.
Where is Lygos located?
Lygos is located in Emeryville, United States.
Is Lygos a funded company?
Lygos is a funded company, its first funding round was on 2011.
When was the latest funding round of Lygos?
Lygos's latest funding round was on Feb 09, 2021.
What is the annual revenue of Lygos?
Annual revenue of Lygos is undefined as on undefined.
Our Lite Plan Awaits you - Its Free!
Sign up now to unlock full access to curated data
  • check icon 4M+ Companies
  • check icon 212K+ Investors
  • check icon 580K+ Funding Rounds
  • check icon 207K+ Acquisitions
  • check icon 2.9K+ Sectors
  • check icon 57K+ Business Models

Accel PartnersPartechIN-Q-TEL - USPalo Alto NetworkMaersk GrowthFujitsuTenityStanford
Are you a Founder ?
Explore our recently published companies
Unlock full details of this profile with our freeÌýLiteÌý±è±ô²¹²Ô!Signup and get free accessÌýarrow-right-long